THE RISKS OF OCCUPATIONAL EXPOSURE AND INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS, HEPATITIS-B VIRUS, AND HEPATITIS-C VIRUS IN THE DIALYSIS SETTING

被引:27
作者
PETROSILLO, N [1 ]
PURO, V [1 ]
JAGGER, J [1 ]
IPPOLITO, G [1 ]
ARICI, C [1 ]
MARCHESI, D [1 ]
DELLAVOLPE, M [1 ]
GILLI, P [1 ]
SOFFRITTI, S [1 ]
GIANGRANDE, A [1 ]
ALLARIA, P [1 ]
ARSIZIO, B [1 ]
CORRADI, MP [1 ]
DURANTI, E [1 ]
LOMBARDI, M [1 ]
VANNINI, M [1 ]
SPADA, S [1 ]
机构
[1] OSPED MALATTIE INFETT LAZZARRO SPALLANZANI,CTR RIFERIMENTO AIDS,I-00149 ROME,ITALY
关键词
D O I
10.1016/0196-6553(95)90057-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The dialysis setting has been recognized as a high-risk environment for transmission to both patients and health care personnel of blood-borne infections, such as hepatitis B virus, hepatitis C virus, and HIV. Methods: A seroprevalence survey of HIV, hepatitis B virus, and hepatitis C virus infection among 1002 patients and a subsequent 1-year surveillance study of percutaneous injuries and skin and mucous membrane contaminations were carried out among 527 health care workers in nine Italian dialysis units. The risks of occupational acquisition of HIV, hepatitis B virus, and hepatitis C virus infections among health care workers were calculated according to a deterministic model. Results: HIV antibody, hepatitis B surface antigen, and hepatitis C antibody prevalences among patients were 0.1%, 5.1%, and 39.4%, respectively. A total of 67 percutaneous injuries, 29 mucous membrane contaminations, and 271 skin contaminations were reported by health care workers. The risk of acquiring infection was calculated to be 4000 and 8000 times lower for HIV than for hepatitis B and C, respectively. Conclusions: The risks of infection with HIV, hepatitis B, and hepatitis C for health care workers at dialysis units differ greatly and depend on the demographic profile and medical history of patients undergoing dialysis. To minimize the risk of exposure to HIV and other blood-borne pathogens, efforts must continue to increase compliance with universal precautions. Needle designs incorporating safety features and improvements in dialysis equipment design are also needed to avoid potential exposure.
引用
收藏
页码:278 / 285
页数:8
相关论文
共 45 条
[1]  
Petrosillo, Puro, Ippolito, The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis, Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients, 64, pp. 636-639, (1993)
[2]  
Alter, Favero, Maynard, Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States, J Infect Dis, 153, pp. 1149-1151, (1986)
[3]  
Alter, Favero, Moyer, Miller, Bland, National surveillance of dialysis-associated diseases in the United States, 1988, ASAIO Trans, 36, pp. 107-118, (1990)
[4]  
Favero, Preventing transmission of hepatitis B in health care facilities, Am J Infect Control, 17, pp. 168-171, (1989)
[5]  
Parsa, Infection in patients on dialysis, Human immunodeficiency virus (HIV) infection and the kidney, 112, pp. 40-45, (1990)
[6]  
Mondelli, Cristina, Piazza, Cerino, Villa, Salvadeo, High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay, Nephron, 61, pp. 350-351, (1992)
[7]  
Besso, Rovere, Peano, Et al., Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit, Nephron, 61, pp. 304-306, (1992)
[8]  
Franco, Olivadese, Valeri, Albertoni, Petrosillo, Control of hepatitis B virus infection in dialysis units in Latium, Italy, Nephron, 61, pp. 329-330, (1992)
[9]  
Petrosillo, Scaccia, Puro, Ippolito, Hepatitis C transmission in dialysis, Nephron, 63, (1993)
[10]  
Cariani, Zonaro, Primi, Et al., Detection of HCV RNA and antibodies to HCV after needlestick injury, Lancet, 337, (1991)